Literature DB >> 9848338

Neurological complications of 5-fluorouracil chemotherapy: case report and review of the literature.

H A Bygrave1, J I Geh, Y Jani, R Glynne-Jones.   

Abstract

Neurological complications of 5-fluorouracil (5-FU) chemotherapy are uncommon events. The two patients presented demonstrate two manifestations of 5-FU neurotoxicity, namely a cerebellar syndrome in association with global motor weakness and bulbar palsy, and a bilateral third cranial (oculomotor) nerve palsy. Both highlight the rapid onset and severity of these unusual side effects but also emphasize that, unlike paraneoplastic syndromes or central nervous system involvement by tumour, complete spontaneous recovery is a potential outcome.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9848338     DOI: 10.1016/s0936-6555(98)80093-9

Source DB:  PubMed          Journal:  Clin Oncol (R Coll Radiol)        ISSN: 0936-6555            Impact factor:   4.126


  6 in total

1.  Seizures following subconjunctival 5-FU therapy.

Authors:  René Hoehn; Julia Lamparter; Norbert Pfeiffer; Urs Vossmerbaeumer
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-03-30       Impact factor: 3.117

2.  CF101, an agonist to the A3 adenosine receptor, enhances the chemotherapeutic effect of 5-fluorouracil in a colon carcinoma murine model.

Authors:  Sara Bar-Yehuda; Lea Madi; Daniel Silberman; Slosman Gery; Maya Shkapenuk; Pnina Fishman
Journal:  Neoplasia       Date:  2005-01       Impact factor: 5.715

Review 3.  Optic neuropathy in cancer patients. Report of a case possibly related to 5 fluorouracil toxicity and review of the literature.

Authors:  L Delval; J Klastersky
Journal:  J Neurooncol       Date:  2002-11       Impact factor: 4.130

4.  Drug-Drug Interactions and Pharmacogenomic Evaluation in Colorectal Cancer Patients: The New Drug-PIN® System Comprehensive Approach.

Authors:  Michela Roberto; Alessandro Rossi; Martina Panebianco; Leda Marina Pomes; Giulia Arrivi; Debora Ierinò; Maurizio Simmaco; Paolo Marchetti; Federica Mazzuca
Journal:  Pharmaceuticals (Basel)       Date:  2021-01-15

5.  Systemic 5-fluorouracil treatment causes a syndrome of delayed myelin destruction in the central nervous system.

Authors:  Ruolan Han; Yin M Yang; Joerg Dietrich; Anne Luebke; Margot Mayer-Pröschel; Mark Noble
Journal:  J Biol       Date:  2008-04-22

6.  An update on the cerebellar subtype of multiple system atrophy.

Authors:  Ludovico Ciolli; Florian Krismer; Ferdinando Nicoletti; Gregor K Wenning
Journal:  Cerebellum Ataxias       Date:  2014-10-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.